LATIN AMERICA
Additionally , the company faces a low turnover in their production area , denoting INTI ’ s tradition in talent management . “ We have no problem in attracting new employees and little people leave , it is all in how we treat them and invest in their development ,” said Schilling .
Pharmaceutical technology
To protect the safety , efficiency and purity in drugs , Drogueria INTI acquired a new factory to manufacture their medicine in 2002 . The company invested US $ 8 million in first-class equipment , followed European standards in the design and construction of the plant , and integrated best practices in manufacturing BPM - GMD . Today , the factory is considered one of Latin America ’ s best plants . Under Schilling ’ s leadership , the company continues to upgrade its methods and renewing medical equipment according to national and global regulations led by WHO - World Health Organization . “ We are always improving our technical equipment , but as we are a competitive player in the pharmaceutical industry , we are used to renovating our plant ,” said Schilling . In early 2016 , INTI will receive new European machinery , such as new Uhlmann blisters , COURTOY tablet press , etc . which will increase productivity and efficiency .
Metisan , one of INTI ’ s most representative products
Chispitas , nutritional supplement of INTI
Brand INTI
www . inti . com . bo 67